Finland· FI-REL-REL54331
Valganciclovir Accord
A valganciclovir product containing valganciclovir hydrochloride, registered in Finland by Orifarm Oy. The same ATC class is registered in 18 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Valganciclovir is registered in 18 of 19 countries.
Countries holding a registration under ATC J05AB14 (valganciclovir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 11 of them publish a price we can compare per daily dose
Valganciclovir · ATC J05AB14
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valganciclovir costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), the median price runs from $3.83 in United States to $35.27 in Italy — a ×9.2 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Valganciclovir · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- IT Italy$35.27
- CH Switzerland$35.18
- FR France$22.39
- US United States$3.83 (acquisition cost)
The record
At a glance
Fimea (Finland)- Active substance
- Valganciclovir hydrochloride
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- J05AB14
- ATC class
- Valganciclovir
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa55175360EUR 1100
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
283 interactions on record for valganciclovir.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valganciclovir · interactions on record
283 records
- 8 severe
- 193 moderate
- 82 info
Most severe, free to view
- CladribineL01BB04severe
- TrospiumA03AB20moderate
- Amphotericin BA07AA07moderate
- TrospiumG04BD09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valganciclovir in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYTEVIX+pharma arzneimittel gmbh, Graz
- United StatesValcyteH2-Pharma, LLC
- NetherlandsAlvanocyt 450 mg, filmomhulde tablettenZentiva k.s.
- SpainVALCYTE 450 mg COMPRIMIDOS RECUBIERTOS CON PELICULA.Cheplapharm Arzneimittel Gmbh
- FranceROVALCYTE 450 mg, comprimé pelliculéCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- SwedenValganciclovir Accord 450 mg Filmdragerad tablettAccord Healthcare B.V.
- ItalyVALCYTECHEPLAPHARM ARZNEIMITTEL GMBH
- NorwayValcyteCheplapharm Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Valcyte, Valganciclovir +pharma
- Belgium · Valcyte, Valganciclovir Sandoz
- Bulgaria · Алваноцит, Валцит
- Cyprus · Valcyte, Valganciclovir Accord
- Czechia · Cytevix, Valcyte
- Germany · Valcyte, Valganaxiro
- Denmark · Valcyte, Valganciclovir "medical Valley"
- Estonia · Valganciclovir Accord, Valganciclovir Sandoz
- Spain · Valcyte, Valganciclovir Accord
- France · Rovalcyte, Valganciclovir Accord
- United Kingdom (Northern Ireland) · Valcyte, Valganciclovir Accord Healthcare
- Greece · Vagotrosin, Valcyte
- Croatia · Alvanocyt, Valcyte
- Hungary · Valcyte, Valdamin
- Ireland · Valcyte, Valganciclovir Accord Healthcare
- Iceland · Valcyte, Valganciclovir Medical Valley
- Italy · Valcyte, Valganciclovir Accord
- Lithuania · Valganciclovir Accord, Valganciclovir Sandoz
- Luxembourg · Valcyte
- Latvia · Valcyte, Valganciclovir Accord
- Netherlands · Alvanocyt, Valcyte
- Norway · Valcyte, Valganciclovir Accord
- Poland · Ceglar, Valcyte
- Portugal · Rovalcyte, Valganciclovir Accord
- Romania · Valganciclovir Zentiva
- Sweden · Valcyte, Valganciclovir Accord
- Slovenia · Ganaxa, Valcyte
- Slovakia · Valdamin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db482a67-8af6-445f-afaf-32816fb18fd0 GET /v1/drugs/db482a67-8af6-445f-afaf-32816fb18fd0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.9",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "450 mg",
"atc_label": "valgansikloviiri",
"ma_number": "36873",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL54331",
"authorised_at": "2019-07-25"
}See everything about valganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.